(Q47973593)

7 February 2018

title

Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling. (English)

1 reference

7 February 2018

0 references

Hjelmström P

1

1 reference

7 February 2018

DeWeese-Scott C

2

1 reference

7 February 2018

Penzotti JE

3

1 reference

7 February 2018

Lybrand TP

4

1 reference

7 February 2018

Sanjeevi CB

5

1 reference

7 February 2018

publication date

1 May 1998

1 reference

7 February 2018

Journal of Neuroimmunology

published in

1 reference

7 February 2018

volume

85

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

102-105

1 reference

7 February 2018

describes a project that uses

1 reference

Characterization of a Novel Reverse-orientation Model for a Peptide/MHC Complex Putatively Associated with Type I Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

Novel method for the rapid evaluation of packing in protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

Polymorphism in tumor necrosis factor genes associated with myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

Identification of a putative motif for binding of peptides to HLA-DQ2

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

HLA-DQB1 codon 57 is critical for peptide binding and recognition.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

PROCHECK: a program to check the stereochemical quality of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900266-X

7 January 2021

10.1016/S0165-5728(97)00266-X

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

9627003

1 reference

7 February 2018